JN AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 89: 2917-2922, 2003. First published January 22, 2003; doi:10.1152/jn.00996.2002
0022-3077/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/6/2917    most recent
00996.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freir, D. B.
Right arrow Articles by Herron, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freir, D. B.
Right arrow Articles by Herron, C. E.

Nicotine Enhances the Depressive Actions of A{beta}1–40 on Long-Term Potentiation in the Rat Hippocampal CA1 Region In Vivo

D. B. Freir and C. E. Herron

Department of Human Anatomy and Physiology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 2, Ireland

Submitted 1 November 2002; accepted in final form 6 January 2003

Hippocampal long-term potentiation (LTP) is a form of synaptic plasticity used as a cellular model of memory. Beta amyloid (A{beta}) is involved in Alzheimer's disease (AD), a neurode-generative disorder leading to cognitive deficits. Nicotine is also claimed to act as a cognitive enhancer. A{beta} is known to bind with high affinity to the {alpha}7-nicotinic acetylcholine receptor (nAChR). Here we have investigated the effect of intracerebroventricular (icv) injection of the endogenous peptide A{beta}1–40 on LTP in area CA1 of urethananesthetized rats. We also examined the effect of A{beta}12–28 (icv), which binds with high affinity to the {alpha}7-nAChR and the specific {alpha}7-nAChR antagonist methyllycaconitine (MLA) on LTP. We found that A{beta}12–28 had no effect on LTP, whereas MLA depressed significantly LTP, suggesting that activation of the {alpha}7-nAChR is a requirement for LTP. Within the in vivo environment, where other factors may compete with A{beta}12–28 for binding to {alpha}7-nAChR, it does not appear to modulate LTP. To determine if the depressive action of A{beta}1–40 on LTP could be modulated by nicotine, these agents were also co-applied. Injection of 1 or 10 nmol A{beta}1–40 caused a significant depression of LTP, whereas nicotine alone (3 mg/kg) had no effect on LTP. Co-injection of nicotine with A{beta}1–40 1 h prior to LTP induction caused a further significant depression of LTP compared with A{beta}1–40 alone. These results demonstrate that nicotine enhances the deficit in LTP produced by A{beta}1–40. This then suggests that nicotine may exacerbate the depressive actions of A{beta} on synaptic plasticity in AD.


Address for reprint requests: C. E. Herron, Department of Human Anatomy and Physiology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Earlsfort Terrace, Dublin 2, Ireland (E-mail: Caroline.Herron{at}ucd.ie).




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. M. Minogue, A. W. Schmid, M. P. Fogarty, A. C. Moore, V. A. Campbell, C. E. Herron, and M. A. Lynch
Activation of the c-Jun N-terminal Kinase Signaling Cascade Mediates the Effect of Amyloid-{beta} on Long Term Potentiation and Cell Death in Hippocampus: A ROLE FOR INTERLEUKIN-1{beta}?
J. Biol. Chem., July 18, 2003; 278(30): 27971 - 27980.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. B. Freir, D. A. Costello, and C. E. Herron
A{beta}25-35-Induced Depression of Long-Term Potentiation in Area CA1 In Vivo and In Vitro Is Attenuated by Verapamil
J Neurophysiol, June 1, 2003; 89(6): 3061 - 3069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the The American Physiological Society.